<DOC>
	<DOC>NCT01676922</DOC>
	<brief_summary>This observational study will evaluate the use of Avastin (bevacizumab) and conventional chemotherapy in patients &gt;/= 70 years of age with previously untreated metastatic colorectal cancer. Data will be collected from each patient from initiation of treatment until disease progression occurs (minimum follow-up 12 months).</brief_summary>
	<brief_title>An Observational Study of Avastin and Conventional Chemotherapy in Patients &gt;/= 70 Years of Age With Previously Untreated Metastatic Colorectal Cancer (AVAPLUS)</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Adult patients, &gt;/ 70 years of age Previously untreated metastatic colorectal cancer Patient considered suitable to receive chemotherapy with or without Avastin Participation in any other clinical trial or study with the exception of participation in registries</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>